Previous observational studies have shown that obesity is associated with elevated serum PCSK9 levels [18, 19], and rising circulating PCSK9 levels have been linked to a reduced response to PCSK9 inhibitors [16]. This evidence concerns the gene PCSK9 and obesity due to melanocortin 4 receptor deficiency.